

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 6.11191877 |
| 2 | doxorubicin metabolic process (GO:0044598) | 6.11191877 |
| 3 | daunorubicin metabolic process (GO:0044597) | 6.11191877 |
| 4 | proline transport (GO:0015824) | 4.50419677 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 4.34852101 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.25854782 |
| 7 | hormone catabolic process (GO:0042447) | 4.13980459 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.09569160 |
| 9 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.02106782 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.99260903 |
| 11 | somite rostral/caudal axis specification (GO:0032525) | 3.98082747 |
| 12 | positive regulation of histone deacetylation (GO:0031065) | 3.90473628 |
| 13 | cellular modified amino acid catabolic process (GO:0042219) | 3.75487236 |
| 14 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.72670751 |
| 15 | histone H4-K8 acetylation (GO:0043982) | 3.67483202 |
| 16 | histone H4-K5 acetylation (GO:0043981) | 3.67483202 |
| 17 | coenzyme catabolic process (GO:0009109) | 3.54849881 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 3.52977957 |
| 19 | response to dietary excess (GO:0002021) | 3.52020567 |
| 20 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.50686457 |
| 21 | response to peptidoglycan (GO:0032494) | 3.49686801 |
| 22 | protein localization to endosome (GO:0036010) | 3.44186917 |
| 23 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.39416293 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.36469171 |
| 25 | negative regulation of epidermis development (GO:0045683) | 3.34020515 |
| 26 | regulation of response to osmotic stress (GO:0047484) | 3.32523307 |
| 27 | histone H4-K12 acetylation (GO:0043983) | 3.31694442 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30547500 |
| 29 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.27640873 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.22315298 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.22315298 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.22315298 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.22315298 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.22315298 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.22315298 |
| 36 | mitochondrion distribution (GO:0048311) | 3.21418471 |
| 37 | phenol-containing compound catabolic process (GO:0019336) | 3.19961713 |
| 38 | negative regulation of cell size (GO:0045792) | 3.19577845 |
| 39 | muscle organ morphogenesis (GO:0048644) | 3.19046685 |
| 40 | pre-miRNA processing (GO:0031054) | 3.18924849 |
| 41 | epoxygenase P450 pathway (GO:0019373) | 3.17174222 |
| 42 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.17086740 |
| 43 | NLS-bearing protein import into nucleus (GO:0006607) | 3.15959388 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.13260736 |
| 45 | positive regulation of protein deacetylation (GO:0090312) | 3.12755947 |
| 46 | negative regulation of telomerase activity (GO:0051974) | 3.12157004 |
| 47 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05012566 |
| 48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.02740822 |
| 49 | notochord development (GO:0030903) | 3.01623032 |
| 50 | histone H4-K16 acetylation (GO:0043984) | 3.00257517 |
| 51 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.99429820 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98562224 |
| 53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97829197 |
| 54 | primitive streak formation (GO:0090009) | 2.96669566 |
| 55 | protein targeting to Golgi (GO:0000042) | 2.95804204 |
| 56 | heterochromatin organization (GO:0070828) | 2.89754313 |
| 57 | hypotonic response (GO:0006971) | 2.88478963 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88137197 |
| 59 | detection of temperature stimulus (GO:0016048) | 2.86890210 |
| 60 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86710958 |
| 61 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.86213917 |
| 62 | detection of other organism (GO:0098543) | 2.86133343 |
| 63 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.85902634 |
| 64 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.85879450 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 2.84521265 |
| 66 | cytidine deamination (GO:0009972) | 2.83811227 |
| 67 | cytidine metabolic process (GO:0046087) | 2.83811227 |
| 68 | cytidine catabolic process (GO:0006216) | 2.83811227 |
| 69 | sulfur amino acid catabolic process (GO:0000098) | 2.81074266 |
| 70 | barbed-end actin filament capping (GO:0051016) | 2.78407079 |
| 71 | vitamin A metabolic process (GO:0006776) | 2.78269332 |
| 72 | mannose metabolic process (GO:0006013) | 2.77361866 |
| 73 | intestinal epithelial cell development (GO:0060576) | 2.76660007 |
| 74 | stress granule assembly (GO:0034063) | 2.76342804 |
| 75 | establishment of protein localization to Golgi (GO:0072600) | 2.75636972 |
| 76 | detection of external biotic stimulus (GO:0098581) | 2.75404102 |
| 77 | maintenance of protein localization in organelle (GO:0072595) | 2.74878129 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.73799250 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.73799250 |
| 80 | glycosphingolipid catabolic process (GO:0046479) | 2.72801801 |
| 81 | regulation of early endosome to late endosome transport (GO:2000641) | 2.72141006 |
| 82 | response to laminar fluid shear stress (GO:0034616) | 2.69981651 |
| 83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69216026 |
| 84 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68314460 |
| 85 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.64659364 |
| 86 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.63625688 |
| 87 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.63052855 |
| 88 | response to muramyl dipeptide (GO:0032495) | 2.62387243 |
| 89 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59094660 |
| 90 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.57567854 |
| 91 | stress fiber assembly (GO:0043149) | 2.57089293 |
| 92 | ovulation cycle (GO:0042698) | 2.55614444 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52563040 |
| 94 | maternal placenta development (GO:0001893) | 2.52509672 |
| 95 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.52298970 |
| 96 | germinal center formation (GO:0002467) | 2.52202064 |
| 97 | detection of bacterium (GO:0016045) | 2.51733521 |
| 98 | regulation of hippo signaling (GO:0035330) | 2.51629171 |
| 99 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51618253 |
| 100 | macroautophagy (GO:0016236) | 2.50178641 |
| 101 | apoptotic cell clearance (GO:0043277) | 2.49556041 |
| 102 | positive regulation of type 2 immune response (GO:0002830) | 2.49453533 |
| 103 | sodium ion export (GO:0071436) | 2.49403322 |
| 104 | protein localization to kinetochore (GO:0034501) | 2.49114850 |
| 105 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.46963795 |
| 106 | bone trabecula formation (GO:0060346) | 2.46611152 |
| 107 | detection of biotic stimulus (GO:0009595) | 2.46252040 |
| 108 | positive regulation of receptor recycling (GO:0001921) | 2.45410368 |
| 109 | cell migration involved in gastrulation (GO:0042074) | 2.44927656 |
| 110 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.44501375 |
| 111 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43928949 |
| 112 | glycolipid catabolic process (GO:0019377) | 2.42914118 |
| 113 | regulation of leukocyte degranulation (GO:0043300) | 2.42128974 |
| 114 | mitochondrion localization (GO:0051646) | 2.42025960 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41338880 |
| 116 | locomotory exploration behavior (GO:0035641) | 2.41201477 |
| 117 | glutamate secretion (GO:0014047) | 2.40371159 |
| 118 | establishment of nucleus localization (GO:0040023) | 2.40351355 |
| 119 | biotin metabolic process (GO:0006768) | 2.40251597 |
| 120 | retinoic acid receptor signaling pathway (GO:0048384) | 2.38998957 |
| 121 | nuclear pore complex assembly (GO:0051292) | 2.37828541 |
| 122 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.37525393 |
| 123 | cortical actin cytoskeleton organization (GO:0030866) | 2.36615465 |
| 124 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36435313 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.35926481 |
| 126 | neutrophil activation involved in immune response (GO:0002283) | 2.34732259 |
| 127 | macrophage activation (GO:0042116) | 2.34483469 |
| 128 | nerve growth factor signaling pathway (GO:0038180) | 2.32936607 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.31510668 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.31510668 |
| 131 | response to type I interferon (GO:0034340) | 2.30329602 |
| 132 | cell-cell junction maintenance (GO:0045217) | 2.30252010 |
| 133 | cardiovascular system development (GO:0072358) | 2.29710350 |
| 134 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.29555705 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.28466311 |
| 136 | layer formation in cerebral cortex (GO:0021819) | 2.28386700 |
| 137 | receptor recycling (GO:0001881) | 2.28105598 |
| 138 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.27600258 |
| 139 | adherens junction assembly (GO:0034333) | 2.27286959 |
| 140 | nucleoside transmembrane transport (GO:1901642) | 2.26354349 |
| 141 | RNA stabilization (GO:0043489) | 2.24506804 |
| 142 | mRNA stabilization (GO:0048255) | 2.24506804 |
| 143 | regulation of ARF GTPase activity (GO:0032312) | 2.23732709 |
| 144 | transepithelial transport (GO:0070633) | 2.23087391 |
| 145 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.23047868 |
| 146 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.22274447 |
| 147 | embryonic process involved in female pregnancy (GO:0060136) | 2.20367611 |
| 148 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.20062716 |
| 149 | positive regulation of axon extension (GO:0045773) | 2.19638357 |
| 150 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.18308837 |
| 151 | plasma membrane repair (GO:0001778) | 2.18046788 |
| 152 | regulation of apoptotic cell clearance (GO:2000425) | 2.17600139 |
| 153 | regulation of cilium movement (GO:0003352) | 2.17548752 |
| 154 | cardiac muscle cell proliferation (GO:0060038) | 2.16181241 |
| 155 | regulation of podosome assembly (GO:0071801) | 2.15675783 |
| 156 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.15662831 |
| 157 | negative regulation of fatty acid transport (GO:2000192) | 2.15622573 |
| 158 | cortical cytoskeleton organization (GO:0030865) | 2.14949296 |
| 159 | regulation of cholesterol homeostasis (GO:2000188) | 2.14380850 |
| 160 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.13875250 |
| 161 | tachykinin receptor signaling pathway (GO:0007217) | 2.13792883 |
| 162 | basement membrane organization (GO:0071711) | 2.13691549 |
| 163 | response to manganese ion (GO:0010042) | 2.13681529 |
| 164 | rRNA transcription (GO:0009303) | 2.13469327 |
| 165 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.13306994 |
| 166 | microtubule severing (GO:0051013) | 2.13099921 |
| 167 | positive regulation of leukocyte degranulation (GO:0043302) | 2.11855493 |
| 168 | regulation of regulated secretory pathway (GO:1903305) | 2.11781537 |
| 169 | signal complex assembly (GO:0007172) | 2.11376999 |
| 170 | T-helper 1 type immune response (GO:0042088) | 2.10831928 |
| 171 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.10717731 |
| 172 | modulation by symbiont of host cellular process (GO:0044068) | 2.09178435 |
| 173 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.08554133 |
| 174 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.07815753 |
| 175 | negative regulation of type 2 immune response (GO:0002829) | 2.06271160 |
| 176 | response to thyroid hormone (GO:0097066) | 2.05666689 |
| 177 | focal adhesion assembly (GO:0048041) | 2.05556493 |
| 178 | cell-substrate adherens junction assembly (GO:0007045) | 2.05556493 |
| 179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.05183441 |
| 180 | regulation of macrophage cytokine production (GO:0010935) | 2.04275678 |
| 181 | regulation of mast cell degranulation (GO:0043304) | 2.04258584 |
| 182 | L-amino acid import (GO:0043092) | 2.03440386 |
| 183 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.02948030 |
| 184 | pinocytosis (GO:0006907) | 2.01533459 |
| 185 | regulation of interferon-alpha production (GO:0032647) | 2.00958230 |
| 186 | regulation of gamma-delta T cell activation (GO:0046643) | 2.00950694 |
| 187 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.00844016 |
| 188 | response to host (GO:0075136) | 2.00844016 |
| 189 | response to host defenses (GO:0052200) | 2.00844016 |
| 190 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.00779177 |
| 191 | response to host immune response (GO:0052572) | 1.99912356 |
| 192 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.99912356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.28472152 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.28472152 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.28472152 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82120935 |
| 5 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.09719376 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.48556697 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.37929448 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19746088 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17565113 |
| 10 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.13247369 |
| 11 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.12938930 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12203676 |
| 13 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.09691406 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00752752 |
| 15 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.98612937 |
| 16 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.95328295 |
| 17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.94811223 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92847149 |
| 19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.89541368 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87603270 |
| 21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.85812924 |
| 22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.85369578 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85230191 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84898190 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84665054 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82097535 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81386969 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80685576 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78307130 |
| 30 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.76539116 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73026232 |
| 32 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.72992609 |
| 33 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.72061420 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.70372049 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68369545 |
| 36 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.66674820 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63882839 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62045304 |
| 39 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58035498 |
| 40 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57081398 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56051237 |
| 42 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.55565935 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54100699 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53316948 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51073488 |
| 46 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.50545303 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49449660 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47460298 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46372725 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45385752 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44252371 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41929507 |
| 53 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.40098146 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.39599098 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.38771040 |
| 56 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.37933756 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37510370 |
| 58 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.37504731 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37277771 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35728262 |
| 61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35633344 |
| 62 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.33783905 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32663463 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30604965 |
| 65 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.29167148 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28978989 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28953167 |
| 68 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28216002 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28121890 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26142250 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25226850 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24495889 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.22832333 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22517606 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22517606 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22500760 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22109180 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21994394 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21872866 |
| 80 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.21444931 |
| 81 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.21085144 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20985109 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20938846 |
| 84 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.20883468 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20845026 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19672992 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19671227 |
| 88 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18579144 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18106365 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16096054 |
| 91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15867992 |
| 92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15867992 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15806294 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15262273 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15117718 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14234347 |
| 97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13753230 |
| 98 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13602183 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13061516 |
| 100 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13017546 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12784554 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12522434 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11409636 |
| 104 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10808142 |
| 105 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.10052541 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09267096 |
| 107 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08090412 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07386598 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07009366 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06254619 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06142889 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06101476 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04750383 |
| 114 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04724702 |
| 115 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03835838 |
| 116 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03818237 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03668303 |
| 118 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02217641 |
| 119 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.01860033 |
| 120 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.01719111 |
| 121 | MAF_26560356_Chip-Seq_TH1_Human | 1.01566645 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01265138 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00167902 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99156791 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98990515 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98831240 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98079928 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97768316 |
| 129 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.97714477 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97578985 |
| 131 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.97443390 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96697639 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95800110 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95451478 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95254008 |
| 136 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94792362 |
| 137 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94454071 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94433096 |
| 139 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94339548 |
| 140 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92712087 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92435170 |
| 142 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92004541 |
| 143 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91754954 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91254663 |
| 145 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90664002 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90658698 |
| 147 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90599156 |
| 148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90463584 |
| 149 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.90218778 |
| 150 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89058533 |
| 151 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88319788 |
| 152 | * AR_19668381_ChIP-Seq_PC3_Human | 0.88300934 |
| 153 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88010268 |
| 154 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87675682 |
| 155 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86940377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.48970379 |
| 2 | MP0004858_abnormal_nervous_system | 4.45872300 |
| 3 | MP0003303_peritoneal_inflammation | 4.30361121 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 4.28751145 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 4.00628626 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.56869725 |
| 7 | MP0003011_delayed_dark_adaptation | 3.46049844 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.94240726 |
| 9 | MP0003122_maternal_imprinting | 2.88072870 |
| 10 | MP0005451_abnormal_body_composition | 2.79655595 |
| 11 | MP0003724_increased_susceptibility_to | 2.72880256 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.71467121 |
| 13 | MP0003436_decreased_susceptibility_to | 2.67608107 |
| 14 | MP0004510_myositis | 2.66200177 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.65114104 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.43990844 |
| 17 | MP0005499_abnormal_olfactory_system | 2.41831744 |
| 18 | MP0005394_taste/olfaction_phenotype | 2.41831744 |
| 19 | MP0003690_abnormal_glial_cell | 2.37316498 |
| 20 | MP0003283_abnormal_digestive_organ | 2.36736474 |
| 21 | MP0006082_CNS_inflammation | 2.33073734 |
| 22 | MP0009840_abnormal_foam_cell | 2.28318344 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.11079141 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.10458938 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 2.08380506 |
| 26 | MP0002332_abnormal_exercise_endurance | 2.05727492 |
| 27 | MP0003329_amyloid_beta_deposits | 2.01828264 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.99857057 |
| 29 | MP0003075_altered_response_to | 1.97763190 |
| 30 | MP0002653_abnormal_ependyma_morphology | 1.95990410 |
| 31 | MP0008260_abnormal_autophagy | 1.95208959 |
| 32 | MP0009278_abnormal_bone_marrow | 1.91654918 |
| 33 | MP0000604_amyloidosis | 1.89563728 |
| 34 | MP0005409_darkened_coat_color | 1.89309854 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.89175743 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.88176449 |
| 37 | MP0002419_abnormal_innate_immunity | 1.87226524 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.80407111 |
| 39 | MP0001849_ear_inflammation | 1.77831477 |
| 40 | MP0004947_skin_inflammation | 1.74808499 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.74129819 |
| 42 | MP0003121_genomic_imprinting | 1.71176249 |
| 43 | MP0003045_fibrosis | 1.65837682 |
| 44 | MP0003828_pulmonary_edema | 1.60376341 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.59820368 |
| 46 | MP0005248_abnormal_Harderian_gland | 1.58339255 |
| 47 | MP0004270_analgesia | 1.57503585 |
| 48 | MP0008004_abnormal_stomach_pH | 1.53610206 |
| 49 | MP0005025_abnormal_response_to | 1.51789663 |
| 50 | MP0000920_abnormal_myelination | 1.51396641 |
| 51 | MP0009785_altered_susceptibility_to | 1.50384662 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.47578179 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.44636487 |
| 54 | MP0004043_abnormal_pH_regulation | 1.43464199 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.40684229 |
| 56 | MP0001958_emphysema | 1.36047611 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.35424040 |
| 58 | MP0003879_abnormal_hair_cell | 1.34097120 |
| 59 | MP0003787_abnormal_imprinting | 1.30650485 |
| 60 | MP0005623_abnormal_meninges_morphology | 1.29541986 |
| 61 | MP0000858_altered_metastatic_potential | 1.28067237 |
| 62 | MP0002269_muscular_atrophy | 1.27360926 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.26466533 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.26106562 |
| 65 | MP0003252_abnormal_bile_duct | 1.26041690 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.26016434 |
| 67 | MP0003448_altered_tumor_morphology | 1.24007358 |
| 68 | MP0003279_aneurysm | 1.23883722 |
| 69 | MP0005387_immune_system_phenotype | 1.22684452 |
| 70 | MP0001790_abnormal_immune_system | 1.22684452 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 1.21064848 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.21003691 |
| 73 | MP0003634_abnormal_glial_cell | 1.20820498 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.19163628 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.18585164 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.15640546 |
| 77 | MP0000343_altered_response_to | 1.15389410 |
| 78 | MP0005360_urolithiasis | 1.15236584 |
| 79 | MP0005166_decreased_susceptibility_to | 1.14844489 |
| 80 | MP0003984_embryonic_growth_retardation | 1.11909723 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 1.10458013 |
| 82 | MP0005380_embryogenesis_phenotype | 1.10458013 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.10306356 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 1.09651487 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.06027378 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.03922243 |
| 87 | MP0004272_abnormal_basement_membrane | 1.03216229 |
| 88 | MP0003123_paternal_imprinting | 1.01980149 |
| 89 | MP0005365_abnormal_bile_salt | 1.00380371 |
| 90 | MP0003119_abnormal_digestive_system | 0.99820089 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.99658484 |
| 92 | MP0003935_abnormal_craniofacial_develop | 0.99573447 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.99528601 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.99183620 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.99183620 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.97235766 |
| 97 | MP0001270_distended_abdomen | 0.97123215 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.95907846 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.94937070 |
| 100 | MP0002932_abnormal_joint_morphology | 0.94719164 |
| 101 | MP0005164_abnormal_response_to | 0.94501992 |
| 102 | MP0002092_abnormal_eye_morphology | 0.94468253 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.93261079 |
| 104 | MP0009046_muscle_twitch | 0.91893085 |
| 105 | MP0010030_abnormal_orbit_morphology | 0.91676592 |
| 106 | MP0001851_eye_inflammation | 0.91333640 |
| 107 | MP0005390_skeleton_phenotype | 0.91188502 |
| 108 | MP0002723_abnormal_immune_serum | 0.91032837 |
| 109 | MP0004233_abnormal_muscle_weight | 0.90788235 |
| 110 | MP0008874_decreased_physiological_sensi | 0.90343660 |
| 111 | MP0002970_abnormal_white_adipose | 0.90160026 |
| 112 | MP0002925_abnormal_cardiovascular_devel | 0.88677192 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.88305579 |
| 114 | MP0000733_abnormal_muscle_development | 0.88286847 |
| 115 | MP0000955_abnormal_spinal_cord | 0.87771385 |
| 116 | MP0004087_abnormal_muscle_fiber | 0.87641226 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.86987864 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.86749181 |
| 119 | MP0008770_decreased_survivor_rate | 0.86185927 |
| 120 | MP0009703_decreased_birth_body | 0.85671806 |
| 121 | MP0004130_abnormal_muscle_cell | 0.85421754 |
| 122 | MP0003938_abnormal_ear_development | 0.84826812 |
| 123 | MP0002233_abnormal_nose_morphology | 0.84409263 |
| 124 | MP0000747_muscle_weakness | 0.83927231 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.83910661 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.83723580 |
| 127 | MP0004883_abnormal_blood_vessel | 0.83669773 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.82878614 |
| 129 | MP0000749_muscle_degeneration | 0.82836957 |
| 130 | MP0003635_abnormal_synaptic_transmissio | 0.82138548 |
| 131 | MP0010329_abnormal_lipoprotein_level | 0.81668882 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.81470428 |
| 133 | MP0002139_abnormal_hepatobiliary_system | 0.78916354 |
| 134 | MP0000685_abnormal_immune_system | 0.78365705 |
| 135 | MP0001915_intracranial_hemorrhage | 0.77995855 |
| 136 | MP0004085_abnormal_heartbeat | 0.77856159 |
| 137 | MP0003091_abnormal_cell_migration | 0.77802783 |
| 138 | MP0008469_abnormal_protein_level | 0.77747490 |
| 139 | MP0009764_decreased_sensitivity_to | 0.77381322 |
| 140 | MP0000762_abnormal_tongue_morphology | 0.77119333 |
| 141 | MP0002733_abnormal_thermal_nociception | 0.76434265 |
| 142 | MP0001819_abnormal_immune_cell | 0.75480531 |
| 143 | MP0002108_abnormal_muscle_morphology | 0.75299863 |
| 144 | MP0005670_abnormal_white_adipose | 0.75249659 |
| 145 | MP0005266_abnormal_metabolism | 0.75208531 |
| 146 | MP0005310_abnormal_salivary_gland | 0.74619610 |
| 147 | MP0010630_abnormal_cardiac_muscle | 0.73724143 |
| 148 | MP0002420_abnormal_adaptive_immunity | 0.73337177 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.73196328 |
| 150 | MP0003300_gastrointestinal_ulcer | 0.72886835 |
| 151 | MP0000759_abnormal_skeletal_muscle | 0.72611482 |
| 152 | MP0002084_abnormal_developmental_patter | 0.72539067 |
| 153 | MP0002089_abnormal_postnatal_growth/wei | 0.72252987 |
| 154 | MP0001800_abnormal_humoral_immune | 0.71950493 |
| 155 | MP0000432_abnormal_head_morphology | 0.71331358 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.70123637 |
| 157 | MP0005165_increased_susceptibility_to | 0.69724864 |
| 158 | MP0002405_respiratory_system_inflammati | 0.69651845 |
| 159 | MP0005023_abnormal_wound_healing | 0.69517665 |
| 160 | MP0005464_abnormal_platelet_physiology | 0.68822990 |
| 161 | MP0001293_anophthalmia | 0.68021034 |
| 162 | MP0003632_abnormal_nervous_system | 0.67555619 |
| 163 | MP0002734_abnormal_mechanical_nocicepti | 0.67268372 |
| 164 | MP0001853_heart_inflammation | 0.66833230 |
| 165 | MP0005666_abnormal_adipose_tissue | 0.66821257 |
| 166 | MP0005197_abnormal_uvea_morphology | 0.65949304 |
| 167 | MP0004197_abnormal_fetal_growth/weight/ | 0.65896298 |
| 168 | MP0003755_abnormal_palate_morphology | 0.65842877 |
| 169 | MP0005508_abnormal_skeleton_morphology | 0.65659024 |
| 170 | MP0002063_abnormal_learning/memory/cond | 0.65546964 |
| 171 | MP0002114_abnormal_axial_skeleton | 0.65194383 |
| 172 | MP0002085_abnormal_embryonic_tissue | 0.64542515 |
| 173 | MP0000371_diluted_coat_color | 0.64288775 |
| 174 | MP0005621_abnormal_cell_physiology | 0.64235657 |
| 175 | MP0009115_abnormal_fat_cell | 0.64152224 |
| 176 | MP0003795_abnormal_bone_structure | 0.62918633 |
| 177 | MP0000751_myopathy | 0.62266400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lower motor neuron (HP:0002366) | 5.44306601 |
| 2 | Bilateral microphthalmos (HP:0007633) | 5.34184453 |
| 3 | Hepatoblastoma (HP:0002884) | 5.14840289 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 4.97555712 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62306974 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62306974 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62306974 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.48661357 |
| 9 | Ependymoma (HP:0002888) | 3.42831058 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.34269274 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.26605165 |
| 12 | Difficulty running (HP:0009046) | 3.22067948 |
| 13 | Astrocytoma (HP:0009592) | 3.19586560 |
| 14 | Abnormality of the astrocytes (HP:0100707) | 3.19586560 |
| 15 | Multiple enchondromatosis (HP:0005701) | 3.14249524 |
| 16 | Hand muscle atrophy (HP:0009130) | 3.11648363 |
| 17 | Neoplasm of the heart (HP:0100544) | 3.01103284 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 2.97689449 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.90903999 |
| 20 | Neoplasm of striated muscle (HP:0009728) | 2.87458367 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 2.87079486 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 2.87046766 |
| 23 | Increased connective tissue (HP:0009025) | 2.87010145 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.84178510 |
| 25 | Orchitis (HP:0100796) | 2.81955455 |
| 26 | Loss of speech (HP:0002371) | 2.80152289 |
| 27 | Rib fusion (HP:0000902) | 2.79933115 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.79574317 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.79574317 |
| 30 | Macroorchidism (HP:0000053) | 2.79316993 |
| 31 | Obstructive sleep apnea (HP:0002870) | 2.77060065 |
| 32 | Renal duplication (HP:0000075) | 2.73146431 |
| 33 | Skin nodule (HP:0200036) | 2.59526136 |
| 34 | Amyotrophic lateral sclerosis (HP:0007354) | 2.57574305 |
| 35 | Resting tremor (HP:0002322) | 2.54735798 |
| 36 | Lymphangioma (HP:0100764) | 2.54405940 |
| 37 | Tetraplegia (HP:0002445) | 2.54299117 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.51206954 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50921752 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.48746134 |
| 41 | Optic neuritis (HP:0100653) | 2.48472600 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.48472600 |
| 43 | Amyloidosis (HP:0011034) | 2.45568054 |
| 44 | Myositis (HP:0100614) | 2.44408706 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 2.42618056 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.41335090 |
| 47 | Hypopigmentation of the fundus (HP:0007894) | 2.39105731 |
| 48 | Horizontal nystagmus (HP:0000666) | 2.36015425 |
| 49 | Gingivitis (HP:0000230) | 2.35652076 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.34881593 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34881593 |
| 52 | Pseudobulbar signs (HP:0002200) | 2.33837546 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.32127076 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32071489 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32071489 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32071489 |
| 57 | Thin bony cortex (HP:0002753) | 2.32013116 |
| 58 | Testicular atrophy (HP:0000029) | 2.31722805 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.29466001 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.28734334 |
| 61 | Nuclear cataract (HP:0100018) | 2.28357147 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.28062085 |
| 63 | Rhabdomyosarcoma (HP:0002859) | 2.27437812 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25878306 |
| 65 | Abnormality of the salivary glands (HP:0010286) | 2.25616203 |
| 66 | Glioma (HP:0009733) | 2.24642658 |
| 67 | Hyperventilation (HP:0002883) | 2.24222043 |
| 68 | Broad face (HP:0000283) | 2.24139248 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.23011552 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.22961304 |
| 71 | Abnormality of the musculature of the hand (HP:0001421) | 2.22412156 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.21216486 |
| 73 | Generalized hypotonia (HP:0001290) | 2.20711417 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.19876727 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19533100 |
| 76 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.18653633 |
| 77 | Hypoplasia of the fovea (HP:0007750) | 2.18653633 |
| 78 | Shawl scrotum (HP:0000049) | 2.16489123 |
| 79 | Apathy (HP:0000741) | 2.11833720 |
| 80 | EMG: neuropathic changes (HP:0003445) | 2.11588269 |
| 81 | Hyperacusis (HP:0010780) | 2.10984446 |
| 82 | Glomerulonephritis (HP:0000099) | 2.09337278 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06687739 |
| 84 | Myocardial infarction (HP:0001658) | 2.05921507 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04817295 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.04077244 |
| 87 | Disinhibition (HP:0000734) | 2.03118715 |
| 88 | Flat acetabular roof (HP:0003180) | 2.02411872 |
| 89 | Amblyopia (HP:0000646) | 2.01469198 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 2.01167694 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.00514461 |
| 92 | Large earlobe (HP:0009748) | 1.99610037 |
| 93 | Axonal loss (HP:0003447) | 1.99596111 |
| 94 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.98898427 |
| 95 | Premature rupture of membranes (HP:0001788) | 1.96968335 |
| 96 | Spastic tetraparesis (HP:0001285) | 1.95518593 |
| 97 | Cervical subluxation (HP:0003308) | 1.95328737 |
| 98 | Diminished motivation (HP:0000745) | 1.95144636 |
| 99 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94819130 |
| 100 | Abnormality of complement system (HP:0005339) | 1.93676558 |
| 101 | Fused cervical vertebrae (HP:0002949) | 1.93555027 |
| 102 | Short humerus (HP:0005792) | 1.92747853 |
| 103 | Mitral valve prolapse (HP:0001634) | 1.91966955 |
| 104 | Shallow orbits (HP:0000586) | 1.91715605 |
| 105 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.91379309 |
| 106 | Supernumerary nipples (HP:0002558) | 1.90413691 |
| 107 | Hamartoma of the eye (HP:0010568) | 1.90122756 |
| 108 | Abnormality of chromosome segregation (HP:0002916) | 1.90049045 |
| 109 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.89898016 |
| 110 | Bifid tongue (HP:0010297) | 1.87346819 |
| 111 | Gout (HP:0001997) | 1.87301671 |
| 112 | Onion bulb formation (HP:0003383) | 1.86543791 |
| 113 | Mutism (HP:0002300) | 1.85343201 |
| 114 | Aneurysm (HP:0002617) | 1.85015697 |
| 115 | Distal lower limb muscle weakness (HP:0009053) | 1.83357477 |
| 116 | Complement deficiency (HP:0004431) | 1.82846454 |
| 117 | Open mouth (HP:0000194) | 1.80957096 |
| 118 | Abnormality of the corticospinal tract (HP:0002492) | 1.79485493 |
| 119 | Intestinal fistula (HP:0100819) | 1.78768516 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78732803 |
| 121 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.78588598 |
| 122 | Osteolytic defects of the hand bones (HP:0009699) | 1.78588598 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.77187924 |
| 124 | Status epilepticus (HP:0002133) | 1.76659217 |
| 125 | Abnormality of the pubic bones (HP:0003172) | 1.76526347 |
| 126 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.76067416 |
| 127 | Pathologic fracture (HP:0002756) | 1.75663084 |
| 128 | Periauricular skin pits (HP:0100277) | 1.74981875 |
| 129 | Preauricular pit (HP:0004467) | 1.74981875 |
| 130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73894504 |
| 131 | Skin tags (HP:0010609) | 1.73692823 |
| 132 | Spontaneous hematomas (HP:0007420) | 1.73540802 |
| 133 | Bone pain (HP:0002653) | 1.73207639 |
| 134 | Nervous tissue neoplasm (HP:0030060) | 1.72984335 |
| 135 | Neuroectodermal neoplasm (HP:0030061) | 1.72984335 |
| 136 | Neuroepithelial neoplasm (HP:0030063) | 1.72984335 |
| 137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71873767 |
| 138 | Preauricular skin tag (HP:0000384) | 1.71510564 |
| 139 | Abnormality of the fovea (HP:0000493) | 1.70961785 |
| 140 | Febrile seizures (HP:0002373) | 1.70570766 |
| 141 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.70243219 |
| 142 | Ankyloglossia (HP:0010296) | 1.68759253 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.68156120 |
| 144 | Keratoconjunctivitis sicca (HP:0001097) | 1.68151013 |
| 145 | Focal seizures (HP:0007359) | 1.67774123 |
| 146 | Disproportionate tall stature (HP:0001519) | 1.67165167 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.67041610 |
| 148 | Embryonal renal neoplasm (HP:0011794) | 1.66931059 |
| 149 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66244973 |
| 150 | Cellulitis (HP:0100658) | 1.66093898 |
| 151 | Hyperparathyroidism (HP:0000843) | 1.65974769 |
| 152 | Heterotopia (HP:0002282) | 1.65382919 |
| 153 | Increased CSF protein (HP:0002922) | 1.65084947 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.64900671 |
| 155 | Peritonitis (HP:0002586) | 1.64849295 |
| 156 | Visceral angiomatosis (HP:0100761) | 1.64601547 |
| 157 | Arterial tortuosity (HP:0005116) | 1.62584900 |
| 158 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.62074301 |
| 159 | Hemorrhage of the eye (HP:0011885) | 1.61380362 |
| 160 | Action tremor (HP:0002345) | 1.61364179 |
| 161 | Hemiparesis (HP:0001269) | 1.61353959 |
| 162 | Short 5th finger (HP:0009237) | 1.61116453 |
| 163 | Vacuolated lymphocytes (HP:0001922) | 1.60746034 |
| 164 | Fibroma (HP:0010614) | 1.60556346 |
| 165 | Skin pits (HP:0100276) | 1.60390682 |
| 166 | Uterine leiomyosarcoma (HP:0002891) | 1.60231608 |
| 167 | Leiomyosarcoma (HP:0100243) | 1.60231608 |
| 168 | Excessive salivation (HP:0003781) | 1.59956115 |
| 169 | Drooling (HP:0002307) | 1.59956115 |
| 170 | Subacute progressive viral hepatitis (HP:0006572) | 1.59621343 |
| 171 | Slow saccadic eye movements (HP:0000514) | 1.59327597 |
| 172 | Malnutrition (HP:0004395) | 1.58720208 |
| 173 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.58270588 |
| 174 | Rectal fistula (HP:0100590) | 1.57902537 |
| 175 | Gastrointestinal infarctions (HP:0005244) | 1.56693909 |
| 176 | Deep venous thrombosis (HP:0002625) | 1.54627102 |
| 177 | Increased IgE level (HP:0003212) | 1.54381050 |
| 178 | Dysmetric saccades (HP:0000641) | 1.54216321 |
| 179 | Dementia (HP:0000726) | 1.54120175 |
| 180 | Abnormality of the periventricular white matter (HP:0002518) | 1.53843296 |
| 181 | Vascular tortuosity (HP:0004948) | 1.53029790 |
| 182 | Esophageal varix (HP:0002040) | 1.52478510 |
| 183 | Purpura (HP:0000979) | 1.52375699 |
| 184 | Turricephaly (HP:0000262) | 1.51192039 |
| 185 | Rapidly progressive (HP:0003678) | 1.51100884 |
| 186 | Peripheral demyelination (HP:0011096) | 1.50822025 |
| 187 | Metaphyseal cupping (HP:0003021) | 1.50399374 |
| 188 | Spinal cord lesions (HP:0100561) | 1.50015374 |
| 189 | Syringomyelia (HP:0003396) | 1.50015374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.55652106 |
| 2 | ERN1 | 3.95114414 |
| 3 | GRK5 | 3.68764740 |
| 4 | PRPF4B | 3.12151033 |
| 5 | TYRO3 | 2.56735802 |
| 6 | GRK6 | 2.50417451 |
| 7 | RIPK4 | 2.28833755 |
| 8 | NTRK1 | 2.23437459 |
| 9 | IRAK3 | 2.17018451 |
| 10 | MAP3K9 | 2.15817168 |
| 11 | WNK1 | 2.13645544 |
| 12 | RIPK1 | 2.10557743 |
| 13 | TGFBR2 | 2.00501429 |
| 14 | MAP2K4 | 1.83731860 |
| 15 | CSF1R | 1.78636659 |
| 16 | TYK2 | 1.75731003 |
| 17 | TRIB3 | 1.75275158 |
| 18 | MAPK7 | 1.72389548 |
| 19 | MAP2K3 | 1.69210383 |
| 20 | GRK1 | 1.63760062 |
| 21 | MATK | 1.60692546 |
| 22 | BLK | 1.54415465 |
| 23 | LATS2 | 1.52672956 |
| 24 | MAP3K3 | 1.52138596 |
| 25 | EPHB1 | 1.51024051 |
| 26 | EEF2K | 1.45838490 |
| 27 | PDGFRA | 1.44008454 |
| 28 | SMG1 | 1.42495987 |
| 29 | CAMK4 | 1.41179954 |
| 30 | MARK2 | 1.38338493 |
| 31 | PRKD3 | 1.37142901 |
| 32 | MAP3K10 | 1.35591439 |
| 33 | SIK1 | 1.32192539 |
| 34 | MAP3K7 | 1.29901044 |
| 35 | FGFR3 | 1.29749128 |
| 36 | MAP3K13 | 1.29591352 |
| 37 | TAOK2 | 1.27273824 |
| 38 | MAP3K14 | 1.24650725 |
| 39 | LATS1 | 1.23771284 |
| 40 | PAK6 | 1.23584393 |
| 41 | NTRK3 | 1.21534070 |
| 42 | STK38 | 1.21354911 |
| 43 | FGR | 1.19976747 |
| 44 | ADRBK2 | 1.16714786 |
| 45 | MOS | 1.14597698 |
| 46 | MAP3K1 | 1.14078496 |
| 47 | ZAP70 | 1.13712268 |
| 48 | KSR2 | 1.13420865 |
| 49 | IRAK4 | 1.13338504 |
| 50 | JAK1 | 1.10022845 |
| 51 | LMTK2 | 1.09404379 |
| 52 | PTK2 | 1.08555890 |
| 53 | GRK7 | 1.08240435 |
| 54 | TTK | 1.07558947 |
| 55 | CAMK1D | 1.07418154 |
| 56 | MAP3K11 | 1.07259350 |
| 57 | HIPK2 | 1.06274106 |
| 58 | PRKG2 | 1.04984452 |
| 59 | PDPK1 | 1.04543088 |
| 60 | PKN2 | 1.02106444 |
| 61 | TBK1 | 1.02029924 |
| 62 | MAP3K6 | 1.00347381 |
| 63 | ALK | 0.99977036 |
| 64 | CAMK1G | 0.96630325 |
| 65 | MTOR | 0.95705786 |
| 66 | ICK | 0.94391787 |
| 67 | MAP3K4 | 0.94149914 |
| 68 | STK10 | 0.93338929 |
| 69 | BMX | 0.90939439 |
| 70 | TAOK1 | 0.90434695 |
| 71 | RPS6KA2 | 0.88600064 |
| 72 | AKT3 | 0.87163980 |
| 73 | PAK4 | 0.86850486 |
| 74 | PAK3 | 0.85047602 |
| 75 | MAP3K2 | 0.84088897 |
| 76 | DDR2 | 0.82647371 |
| 77 | RET | 0.79706690 |
| 78 | IRAK2 | 0.79215667 |
| 79 | JAK3 | 0.77943637 |
| 80 | PRKCH | 0.76873216 |
| 81 | DAPK2 | 0.76316941 |
| 82 | ERBB2 | 0.75937706 |
| 83 | TTN | 0.72646664 |
| 84 | EPHA3 | 0.71013765 |
| 85 | PTK6 | 0.66785084 |
| 86 | CAMKK1 | 0.66451976 |
| 87 | NTRK2 | 0.63999642 |
| 88 | ADRBK1 | 0.63133220 |
| 89 | SIK2 | 0.62990446 |
| 90 | MST1R | 0.61331893 |
| 91 | PRKAA1 | 0.60664128 |
| 92 | HCK | 0.59197823 |
| 93 | RPS6KL1 | 0.56762255 |
| 94 | RPS6KC1 | 0.56762255 |
| 95 | MAPK12 | 0.56218815 |
| 96 | SGK3 | 0.55484193 |
| 97 | NEK1 | 0.55045147 |
| 98 | CDK6 | 0.53465349 |
| 99 | KSR1 | 0.52481074 |
| 100 | MINK1 | 0.51440870 |
| 101 | CDC42BPA | 0.50296234 |
| 102 | SGK2 | 0.50091217 |
| 103 | AKT2 | 0.49422244 |
| 104 | SCYL2 | 0.49285793 |
| 105 | PDGFRB | 0.49262744 |
| 106 | MAPK10 | 0.48004711 |
| 107 | IKBKE | 0.47919663 |
| 108 | DYRK1B | 0.47822528 |
| 109 | TNK2 | 0.46822313 |
| 110 | FYN | 0.46243890 |
| 111 | PHKG2 | 0.45295674 |
| 112 | PHKG1 | 0.45295674 |
| 113 | FES | 0.45109805 |
| 114 | EPHA4 | 0.44854331 |
| 115 | SGK494 | 0.44239340 |
| 116 | SGK223 | 0.44239340 |
| 117 | MAP4K1 | 0.44084354 |
| 118 | SIK3 | 0.42986337 |
| 119 | PDK1 | 0.42109776 |
| 120 | FER | 0.41950068 |
| 121 | RPS6KA3 | 0.41073955 |
| 122 | YES1 | 0.40401858 |
| 123 | IRAK1 | 0.40269605 |
| 124 | MAP2K6 | 0.40048460 |
| 125 | MET | 0.39953667 |
| 126 | NEK6 | 0.39575521 |
| 127 | IGF1R | 0.38561039 |
| 128 | STK11 | 0.38408447 |
| 129 | MARK1 | 0.37983282 |
| 130 | PRKD2 | 0.37130719 |
| 131 | CSK | 0.37058447 |
| 132 | EPHA2 | 0.36896533 |
| 133 | CDK5 | 0.35479039 |
| 134 | FGFR2 | 0.35216217 |
| 135 | DMPK | 0.34546733 |
| 136 | INSRR | 0.33459869 |
| 137 | PDK4 | 0.30911190 |
| 138 | PDK3 | 0.30911190 |
| 139 | PRKACG | 0.30351731 |
| 140 | CDK7 | 0.29022577 |
| 141 | FGFR4 | 0.28995331 |
| 142 | JAK2 | 0.28533096 |
| 143 | GSK3A | 0.28167438 |
| 144 | CSNK1E | 0.27888084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.79316849 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42337378 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28511931 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.21585937 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20205949 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99137660 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92820398 |
| 8 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.81552807 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.78894721 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76541538 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57228071 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.52684313 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51627296 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50302068 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.38859269 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.38197665 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.36342856 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35270118 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35264155 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.34803223 |
| 21 | Amoebiasis_Homo sapiens_hsa05146 | 1.34250347 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.34052492 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33688920 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30640005 |
| 25 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30259765 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28821247 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25156736 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24267532 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23714445 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.22671964 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22444939 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22111927 |
| 33 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.19147958 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18140518 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17704735 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17398334 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16208047 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14891585 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14366922 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13277589 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12321268 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11729754 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.09161032 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08321855 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.07169803 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06286549 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05862208 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05702367 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.05226656 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.03601094 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03558040 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.03469379 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02919265 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02286645 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00430620 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97817365 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97666107 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.97413893 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96497749 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95653713 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94627812 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94489964 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93272974 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.92741714 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.92346445 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92260910 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92042839 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89912552 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89541103 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89265492 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.87584952 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.87488335 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85939787 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.85554012 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85361679 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85128081 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.84863686 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84830869 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84815775 |
| 80 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84699243 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84498865 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84125685 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84058404 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83358806 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82914051 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82568473 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82181264 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80950754 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80553588 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80408778 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79108592 |
| 92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78211736 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77142756 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76860942 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76395136 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76260989 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.75678337 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75440985 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.75155441 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73695279 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73670309 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73431890 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71800830 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.71786086 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70874997 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70586319 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69929895 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.69818221 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.69635714 |
| 110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69553797 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67817768 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.67078549 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66704958 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66690436 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66611789 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66294459 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65747267 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65575027 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.65418888 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65299704 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65159452 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.64651760 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64567124 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.63740221 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63373511 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63164791 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62733993 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62176751 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61780564 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61713761 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.61232705 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60150812 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59766244 |
| 134 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59185661 |
| 135 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59068886 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.58888194 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58749292 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.58573596 |
| 139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58333967 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58045615 |
| 141 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57796015 |
| 142 | Melanogenesis_Homo sapiens_hsa04916 | 0.57578709 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57327649 |
| 144 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57013911 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.56813489 |
| 146 | Gap junction_Homo sapiens_hsa04540 | 0.55254936 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55109083 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55021809 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54534691 |
| 150 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54511050 |
| 151 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54503064 |
| 152 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53989563 |
| 153 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53115448 |
| 154 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52805355 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51988872 |
| 156 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51812163 |

